Of the 19 breast cancer cases with HER2 amplification by MIP microarray, 14 cases (74%) showed co-segmental amplification of both chromosome 17q12, the locus for HER2, and 17p11.2-q11.2, the pericentromeric region of chromosome 17 (Table 3). This evidence concerns the gene ERBB2 and breast cancer.